|
|
Volumn 29, Issue 2, 2000, Pages 127-129
|
|
Tumor vaccine strategies that employ dendritic cells and tumor lysates: Experimental and clinical studies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD16 ANTIGEN;
CD27 ANTIGEN;
CD28 ANTIGEN;
CD38 ANTIGEN;
CD4 ANTIGEN;
CD45 ANTIGEN;
CD56 ANTIGEN;
CD57 ANTIGEN;
CD8 ANTIGEN;
GAMMA INTERFERON;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
HERMES ANTIGEN;
HLA A2 ANTIGEN;
INTERLEUKIN 2;
INTERLEUKIN 4;
KEYHOLE LIMPET HEMOCYANIN;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
TUMOR ANTIGEN;
TUMOR VACCINE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CYTOTOXIC T LYMPHOCYTE;
DENDRITIC CELL;
HUMAN;
IMMUNE RESPONSE;
IMMUNIZATION;
LEUKAPHERESIS;
NONHUMAN;
PRIORITY JOURNAL;
|
|
EID: 0034030302
PISSN: 08820139
EISSN: None
Source Type: Journal
DOI: 10.3109/08820130009062295 Document Type: Conference Paper |
|
Times cited : (12)
|
|
References (0)
|
